Owkin and CRO Aviano Sign Master Partnership Agreement to Foster Collaborative Oncology Research
Owkin official newsroom · 行業原文收錄 · 來源發佈：Fri Aug 07 2026 00:00:00 GMT+0000 (Coordinated Universal Time) · 本站收錄：Thu Oct 08 2026 09:09:15 GMT+0000 (Coordinated Universal Time)
已保存的原文節選
PARIS & PORDENONE, Italy — Owkin, the agentic AI company pioneering the first autonomous AI scientist to revolutionize drug discovery and development, and the Centro di Riferimento Oncologico di Aviano (CRO), a leading Italian National Cancer Institute (IRCCS) dedicated to research and care, today announced the signature of a Master Partnership Agreement aimed at facilitating connections and colla
以上為帶出處的原文節選，完整內容請閱讀原始鏈接。自動收錄與主題分類不等於事實核驗。